Sitler, C.A.; Tian, C.; Hamilton, C.A.; Richardson, M.T.; Chan, J.K.; Kapp, D.S.; Leath, C.A., III; Casablanca, Y.; Washington, C.; Chappell, N.P.;
et al. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers 2024, 16, 1071.
https://doi.org/10.3390/cancers16051071
AMA Style
Sitler CA, Tian C, Hamilton CA, Richardson MT, Chan JK, Kapp DS, Leath CA III, Casablanca Y, Washington C, Chappell NP,
et al. Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers. 2024; 16(5):1071.
https://doi.org/10.3390/cancers16051071
Chicago/Turabian Style
Sitler, Collin A., Chunqiao Tian, Chad A. Hamilton, Michael T. Richardson, John K. Chan, Daniel S. Kapp, Charles A. Leath, III, Yovanni Casablanca, Christina Washington, Nicole P. Chappell,
and et al. 2024. "Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States" Cancers 16, no. 5: 1071.
https://doi.org/10.3390/cancers16051071
APA Style
Sitler, C. A., Tian, C., Hamilton, C. A., Richardson, M. T., Chan, J. K., Kapp, D. S., Leath, C. A., III, Casablanca, Y., Washington, C., Chappell, N. P., Klopp, A. H., Shriver, C. D., Tarney, C. M., Bateman, N. W., Conrads, T. P., Maxwell, G. L., Phippen, N. T., & Darcy, K. M.
(2024). Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States. Cancers, 16(5), 1071.
https://doi.org/10.3390/cancers16051071
